Bleichroeder LP Cue Biopharma, Inc. Transaction History
Bleichroeder LP
- $277 Million
- Q2 2024
A detailed history of Bleichroeder LP transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Bleichroeder LP holds 2,861,606 shares of CUE stock, worth $1.95 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
2,861,606
Previous 2,755,028
3.87%
Holding current value
$1.95 Million
Previous $5.21 Million
31.86%
% of portfolio
1.28%
Previous 1.61%
Shares
14 transactions
Others Institutions Holding CUE
# of Institutions
77Shares Held
13.8MCall Options Held
56.1KPut Options Held
11.1K-
Slate Path Capital LP New York, NY2.4MShares$1.63 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$1.38 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$514,5800.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny494KShares$335,9110.0% of portfolio
-
Geode Capital Management, LLC Boston, MA492KShares$334,8700.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $24.1M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...